4. Conclusions and future prospects
Immunotherapy for NSCLC based on DC and T cells is still in the
development stage, and it has been clinically proven to be effective
against certain cancers. Recent studies have shown that the interaction
between the DC and T cells is an emerging strategy for treating NSCLC.
Determining the role of DC-T cell interaction in NSCLC not only helps to
reveal the mechanism of NSCLC but also provides important clues for
treating this cancer. At the same time, based on understanding the
interaction between DC and T cells, engineered DC and CAR-T are of great
potential for treating solid tumors.